English
|
Spanish
Supporting oncology professionals through education
Login
Register
The content on this site is intended for healthcare professionals only
Menu
Home
News
Journal
Video
e
learning
Events
Conferences
About us
Keyword
Breast
Prostate & urology
Lung & pleura
Colorectal & gastro
Melanoma & skin
Head & neck
Ovary & gynaecology
Bone
Brain & nervous system
Haematology oncology
Hepatobiliary pancreatic
Paediatric
Neuroendocrine
Sarcomas
News
Latest news
Sign up for news alerts
Submit your news
Explore
Bone
Brain & nervous system
Breast
Colorectal & gastro
Haematology oncology
Head & neck
Hepatobiliary pancreatic
Lung & pleura
Melanoma & skin
Neuroendocrine
Ovary & gynaecology
Paediatric
Prostate & urology
Sarcomas
Journal information
Journal home
Charges
Editorial board
Founding editors
Editor-in-chief
Contact us
Author information
Submit article
Author guidelines
Editorial policies
Copyright information
Why publish with us
Reviewer information
Reviewer guidelines
Memberships
Videos
Recent videos
Sign up
Explore
Bone
Brain & nervous system
Breast
Colorectal & gastro
Haematology oncology
Head & neck
Hepatobiliary pancreatic
Lung & pleura
Melanoma & skin
Neuroendocrine
Ovary & gynaecology
Paediatric
Prostate & urology
Sarcomas
Conferences
Latest conferences
Sign up for latest coverage
Submit your event
About
e
cancer
About
e
cancer
Our founders
Funding statement
Contact us
Home
News
Journal
Video
e
learning
Events
Conferences
About us
Keyword
Breast
Prostate & urology
Lung & pleura
Colorectal & gastro
Melanoma & skin
Head & neck
Ovary & gynaecology
+
-
Bone
Brain & nervous system
Haematology oncology
Hepatobiliary pancreatic
Paediatric
Neuroendocrine
Sarcomas
e
cancer and the City Cancer Challenge have formed an educational collaboration. Learners who are part of the City Cancer Challenge's project can access additional education provided by them.
Please login or register. Then you can use this button to confirm you are part of this project.
Register for free
Already have an account?
Login
Videos
[900]
News
[2529]
Articles
[103]
Editorials
[3]
Conferences
[82]
e
learning
[19]
Tusamitamab ravtansine versus docetaxel in previously treated advanced...
Prof Benjamin Besse - Gustave Roussy, Paris, France
1 Oct 2024
Cemiplimab monotherapy could be a new treatment option for first line advanced...
Dr Ana Baramidze - Todua Clinic, Tbilisi, Georgia
1 Oct 2024
Comment: Trial updates from GALAXIES Lung-201 and RELATIVITY-104 in NSCLC
Dr Marina Garassino - University of Chicago, Chicago, USA
26 Sep 2024
Amivantamab-lazertinib continue to show benefit as a first-line standard-of...
Dr Marina Garassino - University of Chicago, Chicago, USA
26 Sep 2024
TROP2 expression measured by QCS is a promising predictor of clinical outcomes...
Dr Marina Garassino - University of Chicago, Chicago, USA
26 Sep 2024
No benefit for adjuvant durvalumab in completely resected NSCLC
Prof Glenwood Goss - University of Ottawa, Ottawa, Canada
17 Sep 2024
ESMO 2024: Highlights and analysis
Assoc Prof Bishal Gyawali - Queen's University, Kingston, Canada
16 Sep 2024
Immunotherapy resistance pathways investigated to tailor combination NSCLC...
Prof Pascale Tomasini - Aix-Marseille University, Marseille, France
16 Sep 2024
Mutational-based treatment approach may significantly improve outcomes in...
Dr Andrea Botticelli - Sapienza Università di Roma, Rome, Italy
16 Sep 2024
ESMO 2024: Latest in EGFR mutated NSCLC
Prof Ignacio Gil-Bazo, Dr Mariana Brandão, Prof Benjamin Besse and Prof...
16 Sep 2024
Addition of relatlimab to nivolumab plus platinum-doublet chemo demonstrates...
Prof Nicolas Girard - Institut Curie, Paris, France
14 Sep 2024
Assessment of suicide risk in cancer patients
Prof Sujit Sarkhel - SSKM Hospital, Kolkata, India
10 Sep 2024
<
1
2
3
4
5
...
75
>
More from
e
cancer